April 2019 Stock Considerations

As we find ourselves in the month of April I realize it is time for me to outline my potential stock buy(s) for the next few weeks. Looking at my portfolio and seeing what relative good values are out there it seems that I’m considering “more of the same.” These are the stocks that seem to be on the radar of many in the DGI space as we seek to maximize potential returns with high safe yields. With that being said let’s take a look at my April stock considerations.

First, I am looking at Altria Group, Inc. (MO). Though the stock has come back quite nicely from its recent lows I still like the stock under $60. The juicy yield well north of 5% is still well covered and the negative sentiment around the stock has not abated which still might give those wishing to go long the stock some time to make up their mind and pick up some shares. The last time I added to my MO was back in January.

Next, I’m thinking about buying more AT&T Inc. (T), especially if stock prices go to $30 or below. T was my sole purchase in November as prices remain depressed and yields get pushed ever higher. Sure, there are a lot of near term headwinds this company is currently facing, not least of which is its debt load, but, the dividend still appears to be quite safe and can reward patient shareholders over the long haul. T still remains less than 1% of my taxable account and much less when compared to all three of my portfolios. In other words, I’m still comfortable adding to my position..

Finally, I am looking to buy AbbVie Inc. (ABBV). This was my sole purchase in the month of March as I added some shares to my ROTH account. 2019 has been a tough start for the stock and it is once again trading at levels not seen since October of last year. With a sustainable yield pushing well over 5% this long time holding of mine is looking enticing, especially under $80.

See, more of the same. These three stocks have been on my mind for at least the last four months or so. What do you think about my potential stock buys for the month of April? Are you considering any of these names for your own portfolio? Please let me know below.

Disclosure: Long MO, T, ABBV

12 thoughts on “April 2019 Stock Considerations

  1. I’ve started looking into AbbVie and it’s valuation metrics and dividend yield look attractive… but I need to dig into it’s revenue and profit diversification. I’ve always been hesitant to jump into medical companies due to the regulatory environment and intellectual property constraints.

  2. I like T/MO,but both of them started upward trend recently.Waiting to see if MO will come down a little.
    I am tracking MMM,ITW,NVDA and maybe adding ABBV before ex dividend date.

  3. Keith,

    So many good choices out there right now. The market may be up big time, but there are still so many companies that are definitely undervalued relative to what they bring to the table.

    – Gremlin

  4. Nice list Hut! I’m digging it. I own two of the three (T and ABBV) on your listing. As you said on my post, there are still some gems out there to be found despite the highs. I don’t think you can go wrong with any of those choices.


  5. The list definitely looks familiar as I see those names everywhere for the last few months. Out of those 3, I own only T. I think I would choose MO if I had to choose between those 3 choices, as I recently bought some CVS and don’t want to add another healthcare-related company 🙂

Leave a Comment

CommentLuv badge

This site uses Akismet to reduce spam. Learn how your comment data is processed.